Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 38 | 2024 | 4236 | 3.200 |
Why?
|
Liver Transplantation | 31 | 2024 | 2329 | 2.130 |
Why?
|
Hepatitis C | 8 | 2021 | 1579 | 1.350 |
Why?
|
Kidney Failure, Chronic | 14 | 2024 | 2477 | 1.220 |
Why?
|
Portal Vein | 4 | 2013 | 431 | 1.050 |
Why?
|
Hyperoxaluria, Primary | 3 | 2017 | 23 | 1.030 |
Why?
|
Tissue Donors | 19 | 2024 | 2331 | 0.990 |
Why?
|
Tissue and Organ Procurement | 8 | 2024 | 962 | 0.960 |
Why?
|
Donor Selection | 4 | 2023 | 232 | 0.950 |
Why?
|
Hepatitis C, Chronic | 7 | 2021 | 1018 | 0.860 |
Why?
|
Hepacivirus | 9 | 2021 | 1330 | 0.830 |
Why?
|
BK Virus | 5 | 2021 | 123 | 0.780 |
Why?
|
Kidney Diseases | 3 | 2020 | 2090 | 0.670 |
Why?
|
Polyomavirus Infections | 4 | 2021 | 194 | 0.620 |
Why?
|
Renal Dialysis | 6 | 2021 | 1799 | 0.610 |
Why?
|
Tumor Virus Infections | 4 | 2021 | 438 | 0.590 |
Why?
|
Hepatitis B | 3 | 2021 | 702 | 0.570 |
Why?
|
Living Donors | 9 | 2023 | 641 | 0.560 |
Why?
|
Graft Survival | 17 | 2024 | 3820 | 0.550 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2020 | 782 | 0.510 |
Why?
|
Antiviral Agents | 8 | 2021 | 3039 | 0.500 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2023 | 2291 | 0.470 |
Why?
|
Embolization, Therapeutic | 2 | 2013 | 1418 | 0.440 |
Why?
|
Liver Neoplasms | 7 | 2023 | 4308 | 0.380 |
Why?
|
Transplantation Tolerance | 1 | 2015 | 605 | 0.350 |
Why?
|
Liver Failure, Acute | 3 | 2018 | 181 | 0.340 |
Why?
|
Transplantation, Heterologous | 6 | 2017 | 2382 | 0.320 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.320 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2008 | 24 | 0.300 |
Why?
|
Blood Coagulation Factors | 5 | 2017 | 366 | 0.290 |
Why?
|
Liver Failure | 2 | 2018 | 250 | 0.270 |
Why?
|
Transplantation, Homologous | 5 | 2022 | 4804 | 0.260 |
Why?
|
Anticoagulants | 1 | 2021 | 4785 | 0.260 |
Why?
|
End Stage Liver Disease | 3 | 2023 | 352 | 0.250 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4250 | 0.250 |
Why?
|
Oxalates | 2 | 2017 | 97 | 0.240 |
Why?
|
Organ Transplantation | 4 | 2022 | 1157 | 0.220 |
Why?
|
Pancreas Transplantation | 1 | 2024 | 197 | 0.220 |
Why?
|
Weight Loss | 2 | 2024 | 2682 | 0.210 |
Why?
|
HIV Infections | 7 | 2024 | 17337 | 0.200 |
Why?
|
Humans | 83 | 2024 | 760617 | 0.200 |
Why?
|
Graft Rejection | 7 | 2024 | 4446 | 0.200 |
Why?
|
Postoperative Hemorrhage | 3 | 2014 | 414 | 0.190 |
Why?
|
Quinoxalines | 2 | 2020 | 296 | 0.190 |
Why?
|
Liver | 9 | 2023 | 7512 | 0.190 |
Why?
|
Hepatectomy | 3 | 2020 | 557 | 0.190 |
Why?
|
Retrospective Studies | 27 | 2023 | 80566 | 0.190 |
Why?
|
Liver Cirrhosis | 4 | 2023 | 1926 | 0.180 |
Why?
|
Aminoisobutyric Acids | 1 | 2020 | 39 | 0.180 |
Why?
|
Kidney | 7 | 2023 | 7045 | 0.180 |
Why?
|
Swine, Miniature | 4 | 2018 | 961 | 0.180 |
Why?
|
Hepatitis B virus | 2 | 2021 | 527 | 0.180 |
Why?
|
Organ Preservation | 1 | 2023 | 382 | 0.170 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 2019 | 15 | 0.170 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2004 | 732 | 0.170 |
Why?
|
Perfusion | 2 | 2023 | 1373 | 0.160 |
Why?
|
Leucine | 1 | 2020 | 548 | 0.160 |
Why?
|
Cyclopropanes | 1 | 2020 | 432 | 0.160 |
Why?
|
Proline | 1 | 2020 | 455 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 318 | 0.160 |
Why?
|
Heat Stroke | 1 | 2018 | 29 | 0.160 |
Why?
|
Male | 47 | 2024 | 360358 | 0.150 |
Why?
|
Disease Transmission, Infectious | 2 | 2017 | 561 | 0.150 |
Why?
|
Benzimidazoles | 2 | 2020 | 858 | 0.150 |
Why?
|
Galactosyltransferases | 3 | 2018 | 276 | 0.150 |
Why?
|
Papio | 5 | 2018 | 669 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2004 | 1269 | 0.150 |
Why?
|
Middle Aged | 37 | 2024 | 220584 | 0.150 |
Why?
|
Nephrectomy | 4 | 2017 | 937 | 0.140 |
Why?
|
Aftercare | 1 | 2023 | 913 | 0.140 |
Why?
|
Liver Regeneration | 1 | 2018 | 213 | 0.140 |
Why?
|
Papio hamadryas | 2 | 2013 | 31 | 0.140 |
Why?
|
Esophageal and Gastric Varices | 1 | 2019 | 207 | 0.140 |
Why?
|
Hypertension, Portal | 1 | 2019 | 226 | 0.140 |
Why?
|
Hepatolenticular Degeneration | 1 | 2017 | 72 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 959 | 0.140 |
Why?
|
Immunosuppressive Agents | 4 | 2017 | 4174 | 0.140 |
Why?
|
Adrenal Glands | 1 | 2019 | 552 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2020 | 314 | 0.130 |
Why?
|
Waiting Lists | 4 | 2024 | 764 | 0.130 |
Why?
|
Brain Death | 3 | 2023 | 357 | 0.130 |
Why?
|
Swine | 9 | 2018 | 5907 | 0.120 |
Why?
|
Adult | 31 | 2024 | 220969 | 0.120 |
Why?
|
Veins | 1 | 2019 | 767 | 0.120 |
Why?
|
Death | 2 | 2010 | 674 | 0.120 |
Why?
|
Transplantation Chimera | 2 | 2015 | 594 | 0.120 |
Why?
|
Ribavirin | 1 | 2016 | 392 | 0.120 |
Why?
|
Survival Rate | 7 | 2020 | 12719 | 0.120 |
Why?
|
Animals, Genetically Modified | 5 | 2018 | 1557 | 0.120 |
Why?
|
Female | 43 | 2024 | 392148 | 0.120 |
Why?
|
Motivation | 1 | 2024 | 2003 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.110 |
Why?
|
Postoperative Complications | 8 | 2024 | 15612 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2019 | 1116 | 0.110 |
Why?
|
Sulfonamides | 2 | 2020 | 1977 | 0.110 |
Why?
|
Antibodies, Heterophile | 1 | 2013 | 128 | 0.110 |
Why?
|
Thrombocytopenia | 3 | 2016 | 1182 | 0.100 |
Why?
|
Ureterostomy | 1 | 2012 | 18 | 0.100 |
Why?
|
Informed Consent | 1 | 2019 | 1007 | 0.100 |
Why?
|
Cystostomy | 1 | 2012 | 25 | 0.100 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2016 | 292 | 0.100 |
Why?
|
Protein S Deficiency | 1 | 2011 | 13 | 0.100 |
Why?
|
Hypertension, Malignant | 1 | 2012 | 17 | 0.100 |
Why?
|
Aged | 19 | 2024 | 169042 | 0.100 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2012 | 31 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2838 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2014 | 4533 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1745 | 0.100 |
Why?
|
Polytetrafluoroethylene | 2 | 2011 | 245 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2014 | 4366 | 0.090 |
Why?
|
Bile Ducts | 1 | 2011 | 282 | 0.090 |
Why?
|
Mesentery | 1 | 2011 | 202 | 0.090 |
Why?
|
Creatinine | 2 | 2013 | 1896 | 0.090 |
Why?
|
Treatment Outcome | 15 | 2022 | 64568 | 0.090 |
Why?
|
Hemostasis | 2 | 2023 | 469 | 0.090 |
Why?
|
Ureter | 1 | 2012 | 368 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 2943 | 0.080 |
Why?
|
Carcinoid Tumor | 1 | 2011 | 224 | 0.080 |
Why?
|
Patient Selection | 4 | 2016 | 4237 | 0.080 |
Why?
|
Hematoma | 1 | 2013 | 762 | 0.080 |
Why?
|
Schistosomiasis mansoni | 1 | 2009 | 93 | 0.080 |
Why?
|
Cecum | 1 | 2009 | 233 | 0.080 |
Why?
|
Lymphocele | 1 | 2008 | 18 | 0.080 |
Why?
|
Virus Integration | 2 | 2020 | 304 | 0.080 |
Why?
|
Schistosoma mansoni | 1 | 2009 | 155 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2020 | 2223 | 0.070 |
Why?
|
Pyrrolidines | 2 | 2020 | 338 | 0.070 |
Why?
|
Gene Knockout Techniques | 3 | 2018 | 801 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3634 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2011 | 1096 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1348 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1896 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2013 | 4571 | 0.070 |
Why?
|
Blood Vessel Prosthesis | 2 | 2011 | 951 | 0.070 |
Why?
|
Biopsy | 4 | 2013 | 6762 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 12943 | 0.070 |
Why?
|
Coccidioides | 1 | 2006 | 18 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4403 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1992 | 0.060 |
Why?
|
Coccidioidomycosis | 1 | 2006 | 37 | 0.060 |
Why?
|
Risk Factors | 7 | 2023 | 74115 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1426 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2690 | 0.060 |
Why?
|
Virus Replication | 1 | 2013 | 2427 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2019 | 3232 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 304 | 0.060 |
Why?
|
Melanoma | 1 | 2004 | 5697 | 0.060 |
Why?
|
HIV-1 | 1 | 2022 | 6858 | 0.060 |
Why?
|
Graft Occlusion, Vascular | 1 | 2008 | 537 | 0.060 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 373 | 0.060 |
Why?
|
Liver Function Tests | 3 | 2017 | 524 | 0.060 |
Why?
|
Vascular Patency | 3 | 2016 | 911 | 0.060 |
Why?
|
Prognosis | 6 | 2020 | 29600 | 0.060 |
Why?
|
Intestines | 2 | 2011 | 1909 | 0.060 |
Why?
|
Prospective Studies | 8 | 2023 | 54360 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 1141 | 0.060 |
Why?
|
United States | 3 | 2022 | 72272 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2004 | 5812 | 0.060 |
Why?
|
Peritoneal Neoplasms | 1 | 2011 | 710 | 0.060 |
Why?
|
Hemorrhage | 1 | 2016 | 3418 | 0.060 |
Why?
|
Lymphatic Vessels | 1 | 2008 | 356 | 0.060 |
Why?
|
Drug Combinations | 2 | 2020 | 2048 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8207 | 0.060 |
Why?
|
Hepatic Encephalopathy | 2 | 2012 | 143 | 0.050 |
Why?
|
HIV | 2 | 2022 | 1579 | 0.050 |
Why?
|
Isoantibodies | 1 | 2006 | 671 | 0.050 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 876 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39063 | 0.050 |
Why?
|
Hemostatic Disorders | 1 | 2002 | 3 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1134 | 0.050 |
Why?
|
Antigens, CD | 2 | 2013 | 3998 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8516 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4745 | 0.050 |
Why?
|
Proviruses | 1 | 2022 | 313 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9277 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5672 | 0.050 |
Why?
|
Fatal Outcome | 3 | 2012 | 1835 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2007 | 1397 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2409 | 0.040 |
Why?
|
Antigens, Viral, Tumor | 1 | 2020 | 153 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 1998 | 0.040 |
Why?
|
Chromosome Breakage | 1 | 2020 | 159 | 0.040 |
Why?
|
Animals | 12 | 2018 | 168201 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2178 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2013 | 508 | 0.040 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12966 | 0.040 |
Why?
|
Virus Latency | 1 | 2022 | 354 | 0.040 |
Why?
|
Integrases | 1 | 2022 | 518 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7995 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6807 | 0.040 |
Why?
|
Serologic Tests | 2 | 2017 | 381 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Blood Coagulation Disorders | 1 | 2002 | 350 | 0.040 |
Why?
|
Viremia | 1 | 2021 | 707 | 0.040 |
Why?
|
Cholecystitis | 1 | 1999 | 180 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9476 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 59179 | 0.040 |
Why?
|
Exercise | 2 | 2024 | 5886 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1690 | 0.040 |
Why?
|
Immune Sera | 1 | 1997 | 605 | 0.040 |
Why?
|
Hyperoxaluria | 1 | 2017 | 32 | 0.040 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 1999 | 231 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8618 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6474 | 0.030 |
Why?
|
Genome, Viral | 1 | 2020 | 665 | 0.030 |
Why?
|
Jaundice | 1 | 2017 | 94 | 0.030 |
Why?
|
Counseling | 1 | 2024 | 1538 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2002 | 1154 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2017 | 957 | 0.030 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2017 | 330 | 0.030 |
Why?
|
Immunization, Passive | 1 | 1997 | 616 | 0.030 |
Why?
|
Reoperation | 2 | 2018 | 4300 | 0.030 |
Why?
|
Immunity, Cellular | 2 | 2013 | 1550 | 0.030 |
Why?
|
Time Factors | 6 | 2016 | 39913 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 462 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2414 | 0.030 |
Why?
|
Health Care Costs | 1 | 2007 | 3238 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2023 | 1859 | 0.030 |
Why?
|
Bilirubin | 2 | 2011 | 435 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2017 | 300 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2010 | 11116 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10505 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2014 | 199 | 0.030 |
Why?
|
Cyclosporine | 1 | 1996 | 778 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3800 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2546 | 0.030 |
Why?
|
Interferon-alpha | 1 | 1997 | 902 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3325 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2014 | 740 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 555 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1782 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2019 | 1590 | 0.030 |
Why?
|
Protein S | 1 | 2011 | 29 | 0.030 |
Why?
|
Child | 4 | 2023 | 80079 | 0.020 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2011 | 65 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 20556 | 0.020 |
Why?
|
Geography | 1 | 2013 | 652 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2017 | 808 | 0.020 |
Why?
|
Delayed Graft Function | 1 | 2011 | 54 | 0.020 |
Why?
|
Biliary Tract Diseases | 1 | 2011 | 159 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1128 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 126 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 362 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3442 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3527 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 30016 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8699 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3415 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3410 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2012 | 324 | 0.020 |
Why?
|
Intracranial Hypertension | 1 | 2012 | 193 | 0.020 |
Why?
|
Child, Preschool | 2 | 2013 | 42188 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2011 | 172 | 0.020 |
Why?
|
Life Expectancy | 1 | 2016 | 1239 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4160 | 0.020 |
Why?
|
Postoperative Period | 1 | 2013 | 1813 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2011 | 860 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2011 | 352 | 0.020 |
Why?
|
Liver Diseases | 1 | 2017 | 1297 | 0.020 |
Why?
|
Endemic Diseases | 1 | 2009 | 190 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2014 | 1299 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4421 | 0.020 |
Why?
|
Splenomegaly | 1 | 2008 | 189 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1409 | 0.020 |
Why?
|
Pancytopenia | 1 | 2008 | 102 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2011 | 432 | 0.020 |
Why?
|
Laparoscopy | 2 | 2009 | 2030 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3797 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7389 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6305 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 346 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2007 | 448 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2112 | 0.020 |
Why?
|
Coma | 1 | 2009 | 484 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 941 | 0.020 |
Why?
|
Resource Allocation | 1 | 2007 | 350 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15828 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4433 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2006 | 901 | 0.010 |
Why?
|
Hematologic Diseases | 1 | 2008 | 496 | 0.010 |
Why?
|
Cadaver | 1 | 2008 | 1358 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1596 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9643 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2722 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5863 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2011 | 1683 | 0.010 |
Why?
|
Radiology Information Systems | 1 | 2007 | 529 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
New England | 1 | 2006 | 1051 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2014 | 18937 | 0.010 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 544 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21337 | 0.010 |
Why?
|
Drainage | 1 | 2008 | 1156 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12933 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2008 | 1070 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13245 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 88234 | 0.010 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1222 | 0.010 |
Why?
|
Fever | 1 | 2008 | 1618 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7960 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5964 | 0.010 |
Why?
|
Models, Animal | 1 | 2006 | 2109 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1835 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18221 | 0.010 |
Why?
|
Platelet Count | 1 | 2002 | 780 | 0.010 |
Why?
|
Heart Arrest | 1 | 2009 | 1513 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18381 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1779 | 0.010 |
Why?
|
Complement System Proteins | 1 | 2002 | 734 | 0.010 |
Why?
|
Brain Injuries | 1 | 2010 | 2053 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2006 | 2299 | 0.010 |
Why?
|
Dogs | 1 | 2002 | 3838 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7847 | 0.010 |
Why?
|
Complement C4 | 1 | 1997 | 216 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5430 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22148 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16571 | 0.010 |
Why?
|
Complement C3 | 1 | 1997 | 434 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1996 | 414 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5491 | 0.010 |
Why?
|
Endothelium | 1 | 1997 | 764 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1996 | 601 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14648 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15251 | 0.010 |
Why?
|
Postoperative Care | 1 | 1997 | 1467 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58894 | 0.010 |
Why?
|
Kinetics | 1 | 1997 | 6370 | 0.010 |
Why?
|
Aorta | 1 | 1997 | 2041 | 0.010 |
Why?
|
Preoperative Care | 1 | 1997 | 2241 | 0.000 |
Why?
|
Acute Disease | 1 | 1999 | 7237 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1997 | 6224 | 0.000 |
Why?
|
Risk Assessment | 1 | 2009 | 23972 | 0.000 |
Why?
|
Cholesterol | 1 | 1996 | 2903 | 0.000 |
Why?
|
Cell Survival | 1 | 1997 | 5780 | 0.000 |
Why?
|
Length of Stay | 1 | 1999 | 6418 | 0.000 |
Why?
|
Recurrence | 1 | 1997 | 8426 | 0.000 |
Why?
|
Blood Glucose | 1 | 1996 | 6390 | 0.000 |
Why?
|
Neoplasms | 1 | 2008 | 22131 | 0.000 |
Why?
|
Brain | 1 | 2006 | 27101 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36402 | 0.000 |
Why?
|